Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2018

View Archived Issues

TGF-beta inhibition restores regeneration in acute liver injury

Discovery of a druggable target for traumatic brain injury

Sumitomo Dainippon Pharma divulges dopamine D1/D2 and/or 5-HT2A receptor antagonists

Biogen patents nuclear factor erythroid 2-related factor 2 activators

Novel animal model of glaucoma created using tree shrews

New lysine-specific histone demethylase 1A inhibitors identified at Medshine Discovery

Elevated FGF23, a causative factor in the development of renal anemia and iron deficiency

Lilly discovers N-Acetyl-beta-D-glucosaminidase inhibitors

FDA approves Opdivo for metastatic SCLC that has progressed after platinum-based chemotherapy

GlaxoSmithKline describes discovery of DNMT1 inhibitors at fall ACS National Meeting

FDA places partial clinical hold on Study OX1222 of OXi-4503

Target of rapamycin complex 1 inhibition improves immune function in elderly subjects

Immunocore initiates phase I study of IMCnyeso under GSK collaboration

Tumors in brain lead to T cells in bone

Vaccinations initiated in first-in-human trial of novel attenuated Zika vaccine

Let there be no light damage

FDA approves Eylea injection sBLA in wet AMD

European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss

Celleron enrolls first patient in phase Ib/II study of CXD-101 with nivolumab for colorectal cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...